Matthew NicolettiCapital markets · Health finance · Strategy
Matthew Nicoletti
Chief Strategy Officer and Director of Perpetuals.com Ltd (opens in a new tab) (Nasdaq: PDC), Senior Scientist of Health Finance at McMaster University, Senior Strategic Advisor to ViRx@Stanford (opens in a new tab), and founder of Vadar Management (opens in a new tab).
Affiliations & coverage
(opens in a new tab)McMaster UniversityViRx@StanfordIHME, University of WashingtonCointelegraphBusiness WireYahoo Finance (opens in a new tab)15+ yearsacross healthcare, technology, finance and real estate
Nasdaq: PDCChief Strategy Officer and Director, Perpetuals.com Ltd
2021TOGETHER Trial, David Sackett Clinical Trial of the Year Award (lead funder)
2016Founded Vadar Management LLC
Matthew Nicoletti is a capital markets executive and health systems financing leader with more than 15 years of experience across healthcare, technology, finance and real estate. His work connects rigorous academic research with large-scale capital deployment, from clinical trial funding to AI-powered fintech.
Current Roles
- Chief Strategy Officer and Director, Perpetuals.com Ltd (opens in a new tab) (Nasdaq: PDC)
- Senior Scientist of Health Finance, Department of Health Research Methods, Evidence, and Impact, McMaster University
- Advisory Board Member and Senior Strategic Advisor, ViRx@Stanford (opens in a new tab)
- Advisor, Global Burden of Disease study, IHME, University of Washington
- President and Founder, Vadar Management LLC
Cointelegraph · Podcast
Chain Reaction with Matthew Nicoletti, Perpetuals Group CSO
Clips on X: July 14, 2026 (opens in a new tab) · July 23, 2026 (opens in a new tab)